These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 10082129)

  • 21. Protein kinase C delta blocks immediate-early gene expression in senescent cells by inactivating serum response factor.
    Wheaton K; Riabowol K
    Mol Cell Biol; 2004 Aug; 24(16):7298-311. PubMed ID: 15282327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coordinate expression and distinct DNA-binding characteristics of the four EGR-zinc finger proteins in Jurkat T lymphocytes.
    Skerka C; Decker EL; Zipfel PF
    Immunobiology; 1997 Dec; 198(1-3):179-91. PubMed ID: 9442390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein.
    Baek SJ; Kim JS; Moore SM; Lee SH; Martinez J; Eling TE
    Mol Pharmacol; 2005 Feb; 67(2):356-64. PubMed ID: 15509713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolutionary conservation of the egr-1 immediate-early gene response in a teleost.
    Burmeister SS; Fernald RD
    J Comp Neurol; 2005 Jan; 481(2):220-32. PubMed ID: 15562507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zinc finger transcription factor Egr-1 is involved in stimulation of NHE2 gene expression by phorbol 12-myristate 13-acetate.
    Malakooti J; Sandoval R; Memark VC; Dudeja PK; Ramaswamy K
    Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G653-63. PubMed ID: 15976391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EGR-1, the reluctant suppression factor: EGR-1 is known to function in the regulation of growth, differentiation, and also has significant tumor suppressor activity and a mechanism involving the induction of TGF-beta1 is postulated to account for this suppressor activity.
    Liu C; Calogero A; Ragona G; Adamson E; Mercola D
    Crit Rev Oncog; 1996; 7(1-2):101-25. PubMed ID: 9109500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence that activation of the Egr-1 promoter by v-Raf involves serum response elements.
    Rim M; Qureshi SA; Gius D; Nho J; Sukhatme VP; Foster DA
    Oncogene; 1992 Oct; 7(10):2065-8. PubMed ID: 1408148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained induction of egr-1 by v-src correlates with a lack of fos-mediated repression of the egr-1 promoter.
    Qureshi SA; Rim MH; Alexandropoulos K; Berg K; Sukhatme VP; Foster DA
    Oncogene; 1992 Jan; 7(1):121-5. PubMed ID: 1741159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group.
    Levin WJ; Press MF; Gaynor RB; Sukhatme VP; Boone TC; Reissmann PT; Figlin RA; Holmes EC; Souza LM; Slamon DJ
    Oncogene; 1995 Oct; 11(7):1261-9. PubMed ID: 7478546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylation of serum response factor by casein kinase II: evidence against a role in growth factor regulation of fos expression.
    Manak JR; Prywes R
    Oncogene; 1993 Mar; 8(3):703-11. PubMed ID: 8437853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transactivation of Krox-20 and Krox-24 promoters by the HTLV-1 Tax protein through common regulatory elements.
    Alexandre C; Charnay P; Verrier B
    Oncogene; 1991 Oct; 6(10):1851-7. PubMed ID: 1833716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EGR3, a novel member of the Egr family of genes encoding immediate-early transcription factors.
    Patwardhan S; Gashler A; Siegel MG; Chang LC; Joseph LJ; Shows TB; Le Beau MM; Sukhatme VP
    Oncogene; 1991 Jun; 6(6):917-28. PubMed ID: 1906159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of Egr-1-dependent gene expression by the C-terminal activation domain.
    Gosslar U; Schmid RM; Holzmann B
    Biochem Biophys Res Commun; 1999 Feb; 255(2):208-15. PubMed ID: 10049687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ternary complex factors Elk-1 and Sap-1a mediate growth hormone-induced transcription of egr-1 (early growth response factor-1) in 3T3-F442A preadipocytes.
    Clarkson RW; Shang CA; Levitt LK; Howard T; Waters MJ
    Mol Endocrinol; 1999 Apr; 13(4):619-31. PubMed ID: 10194767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain.
    Huang RP; Liu C; Fan Y; Mercola D; Adamson ED
    Cancer Res; 1995 Nov; 55(21):5054-62. PubMed ID: 7585551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of early growth response genes in human prostate cancer.
    Eid MA; Kumar MV; Iczkowski KA; Bostwick DG; Tindall DJ
    Cancer Res; 1998 Jun; 58(11):2461-8. PubMed ID: 9622090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The SRE: a growth factor responsive transcriptional regulator.
    Treisman R
    Semin Cancer Biol; 1990 Feb; 1(1):47-58. PubMed ID: 2133110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in the molecular response to DNA damage during cellular aging of cultured fibroblasts: reduced AP-1 activation and collagenase gene expression.
    Choi AM; Pignolo RJ; apRhys CM; Cristofalo VJ; Holbrook NJ
    J Cell Physiol; 1995 Jul; 164(1):65-73. PubMed ID: 7790398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the early growth response 1 gene and nuclear pp90rsk in human myeloid leukemia cells by 1-(beta-D-arabinofuranosyl)cytosine.
    Kharbanda S; Saleem A; Rubin E; Sukhatme V; Blenis J; Kufe D
    Biochemistry; 1993 Sep; 32(35):9137-42. PubMed ID: 7690249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of Egr-1, SRF, and Sp1 mRNA expression in contracting skeletal muscle cells.
    Irrcher I; Hood DA
    J Appl Physiol (1985); 2004 Dec; 97(6):2207-13. PubMed ID: 15310743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.